Mechanism of Inhibition of SARS-CoV-2 Mpro by N3 Peptidyl Michael Acceptor Explained by QM/MM Simulations and Design of New Derivatives with Tunable Chemical Reactivity (2020)

First Author: Arafet K
Attributed to:  Commercialisation of VR for biomolecular design funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26434/chemrxiv.12941819.v1

Publication URI: http://dx.doi.org/10.26434/chemrxiv.12941819.v1

Type: Preprint